hydrolases

LY2183240 是大麻素摄取阻滞剂。它是内源性大麻素降解酶脂肪酸酰胺水解酶的有效共价抑制剂。它抑制脂肪酸酰胺水解酶 (FAAH) 活性，IC50 为12.4 nM。它也抑制其他几种脑丝氨酸水解酶，对 MAG 脂肪酶、bh6 和 KIAA1363 的 IC50分别为 5.3、0.09 和 8.2 nM。

LEI110 是一种有效的 Phospholipase A2, group XVI (PLA2G16) 抑制剂，Ki 值为 20 nM。 LEI110 是 HRASLS 硫醇水解酶家族（即 PLA2G16、HRASLS2、RARRES3 和 iNAT）的选择性泛抑制剂。

BSH-IN-1 是一种重组的肠道细菌胆汁盐水解酶 (BSHs) 的有效和共价抑制剂，对 B. longum BSH (革兰氏阳性) 和 B. theta BSH (革兰氏阴性菌) 的 IC50 分别为 108 和 427 nM。

DNJNAc（亦称 2-Acetamido-1,2-dideoxynojirimycin）是一种高效且特异性的 β-己糖胺酶 (HEX) 抑制剂。HEX 酶催化糖蛋白、神经节苷脂及糖胺聚糖等糖结合物中末端非还原 N-乙酰-β-D-葡萄糖胺 (GlcNAc) 和 N-乙酰-β-D-半乳糖胺 (GalNAc) 的水解。软骨细胞分泌的 HEX 进入细胞外空间，可导致软骨基质降解，使骨关节炎滑液中的 HEX 活性升高。

ABC47 是一种高效的丝氨酸水解酶 (serine hydrolases) 抑制剂，对ABHD4和ABHD3的IC50分别为0.03 μM和0.1 μM。在研究婴儿神经元蜡样脂褐素沉积症方面，ABC47 发挥了重要作用。

(R)-Bromoenol lactone 是不可逆、手性、机理依赖性的 iPLA2γ 抑制剂，对人重组 iPLA2γ 的 IC50 约为 0.6 µM 。

Epoxide hydrolases convert the EETs into vicinal diols, with the concurrent loss of much of their biological activity. The 8(S),9(R)-EET isomer is metabolized by platelet COX to form 8(S),9(R),11(R)-THETA, a trihydroxy fatty acid which may act as a renal vasoconstrictor.

Eicosapentaenoic acid is an ω-3 polyunsaturated fatty acid that is abundant in marine organisms and fish oils. EPA is metabolized, in part, through cytochrome P450-catalyzed epoxidation followed by conversion to the vicinal diols by epoxide hydrolases. (±)5(6)-DiHETE is a possible metabolite produced from EPA following epoxidation of the α-5 double bond. The biological activity of (±)5(6)-DiHETE has not been documented.

(±)5(6)-DiHETE lactone是由(±)5(6)-DiHETE衍生的1,5环酯，可用于特异性定量生物样品中的(±)5(6)-DiHETE。

(±)-11(12)-DiHET is an oxylipin. 11(S),12(S)-DiHET and 11(R),12(R)-DiHET are vicinal diols formedviaenzymatic hydration of 11(12)-EET by cytosolic or soluble epoxide hydrolases in a non-stereoselective manner.1,2,3(±)11(12)-DiHET MaxSpec standard is a quantitative grade standard of (±)11(12)-DiHET that has been prepared specifically for mass spectrometry and related applications where quantitative reproducibility is required. The solution has been prepared gravimetrically and is supplied in a deactivated glass ampule sealed under argon. The concentration was verified by comparison to an independently prepared calibration standard. This (±)11(12)-DiHET MaxSpec standard is guaranteed to meet identity, purity, stability, and concentration specifications and is provided with a batch-specific certificate of analysis. Ongoing stability testing is performed to ensure the concentration remains accurate throughout the shelf life of the product.Note: The amount of solution added to the vial is in excess of the listed amount. Therefore, it is necessary to accurately measure volumes for preparation of calibration standards. Follow recommended storage and handling conditions to maintain product quality.

9(E)-Octadecenamide(Elaidamide)是一种脂肪酸酰胺和内源性代谢物，能够抑制大鼠的mEH（microsomal epoxide hydrolase），Ki=70 nM。

JCP678 is an irreversible serine hydrolases inhibitor.

JZP-MA-13是一种选择性α/β-水解酶结构域6 (ABHD6) 抑制剂，其IC50值为392 nM。该化合物对MAGL、ABHD12、FAAH或其它丝氨酸水解酶不表现出抑制作用。JZP-MA-13还被用作ABHD6在体内成像的正电子发射断层扫描(PET)配体。

Enzyme-IN-1（compound 1）为基于肽的N端亲核试剂（Ntn）水解酶抑制剂，特别针对20S蛋白酶体的糜胰蛋白酶样活性（CT-L）进行抑制，可能展现出抗炎特性。

Carboxylesterase (CESs), 即羧酸酯水解酶，广泛分布于自然界，常见于哺乳动物肝脏，常用于生化研究。Carboxylesterase 催化多种内源和外源底物的水解，包括酯、硫酯、氨基甲酸酯和酰胺，使羧酸酯水解成相应的醇和羧酸。

5(6)-DiHET is a racemic compound synthesized through the action of epoxide hydrolases on 5(6)-EET, encompassing both enantiomeric forms. It serves as a quantitative marker for 5(6)-EET, facilitating its measurement by utilizing the compound's conversion to 5(6)-δ-lactone in solution. Additionally, 5(6)-DiHET activates large-conductance calcium-activated potassium (KCa1.1/BK) channels in rat small coronary artery smooth muscle cells, supporting its biological significance in vascular regulation. It also acts as a substrate for sheep seminal vesicle COX, leading to the in vitro production of 5,6-dihydroxy prostaglandin E1 and F1α metabolites. Notably, its levels diminish in the plasma of rats subjected to a high-fat diet, indicating a potential role in the pathophysiology of hyperlipidemia.

WWL229 是羧酸酯酶3的选择性抑制剂 (IC50:1.94 µM) 。它可作用于培养脂肪细胞，提高脂质的储存，并减少基础脂肪分解。

D-Glucopyranose, 98% (α-Sophorose, 98%) 是一种底物，适用于多种糖苷水解酶如α-葡萄糖苷酶，并用于糖生物学的研究。

2′-Hydroxy-5′-nitrohexadecanamide 是一种溶酶体水解酶 (Lysosomal hydrolase) 的抑制剂，其结构包含十五酸和末端硝基苯酚的脂质。通过抑制溶酶体水解酶的活性，它会导致细胞内脂质的积累。此外，2′-Hydroxy-5′-nitrohexadecanamide 还可以用来合成用于测定鞘磷脂酶活性的显色底物。